Work

Combination therapy with belimumab and low‐dose interleukin‐2 in a patient with anti‐MDA5 antibody dermatomyositis overlapping with systemic lupus erythematosus

FWCI: 0.261
Cites: 5
Cited by: 1
Related to: 10